You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
華潤雙鶴(600062.SH):孫公司地諾孕素原料藥獲得CEP證書
格隆匯 12-25 17:03

格隆匯12月25日丨華潤雙鶴(600062.SH)公佈,公司全資孫公司秦皇島紫竹藥業有限公司(以下簡稱“秦皇島紫竹”)收到了歐洲藥品質量管理局 (European Directorate for the Quality of Medicines &Healthcare,以下簡稱“EDQM”)簽發的地諾孕素原料藥(以下簡稱“該原料藥”)歐洲藥典適用性認證證書(Certificate of Suitability toMonograph of European Pharmacopoeia,以下簡稱“CEP 證書”)。

地諾孕素(第四代孕激素)是一種混合孕激素,同時具有天然和合成孕激素的藥理學優點。地諾孕素在子宮內膜中顯示出強大的孕激素效應和抗雄激素效應,有利於減輕痤瘡和皮脂溢出的發生,用於治療子宮內膜異位症。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account